Chemical Structure : IRX5010
CAS No.: 856683-59-5
货号: PC-23692Not For Human Use, Lab Use Only.
IRX5010 (IRX4647F) is a second generation, potent, highly selective RARγ agonist with EC50 of <0.1 nM in RARγ transactivation reporter assays, >1000-fold selective over RARα.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥3880 | In stock | |
10 mg | ¥5880 | In stock | |
25 mg | ¥8980 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
IRX5010 (IRX4647F) is a second generation, potent, highly selective RARγ agonist with EC50 of <0.1 nM in RARγ transactivation reporter assays, >1000-fold selective over RARα.
IRX5010 demonstrates no significant inhibitory activity in vitro on EMT-6 proliferation at concentrations lower than 20-100 uM.
IRX5010 demonstrates substantial dose dependent treatment effects relative to vehicle control (59-73%) on inhibition of growth of EMT-6 syngeneic murine triple negative breast cancer in vivo.
IRX5010 induces tumor infiltrating T-lymphocytes of effector memory phenotypes, demonstrating immunity promoting effects in the tumor immune microenvironment.
分子量 | 395.47 | |
分子式 | C24H26FNO3 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
3-fluoro-4-((1E,3E)-3-(hydroxyimino)-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl)benzoic acid |
1. Martin Sanders, et al. Cancer Res (2024) 84 (9_Supplement): PO5-24-12.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright